\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ no\\ treatment\\ required\\.\\ \\ since\\ some\\ cases\\ of\\ cavernous\\ malformation\\ are\\ hereditary\\,\\ recommended\\ follow\\ up\\ studies\\ to\\ include\\ gradient\\ echo\\ mr\\ sequence\\ to\\ look\\ for\\ additional\\ lesions\\.\ \(0\)\
\-\ mr\\ images\\ demonstrate\\ a\\ well\\ delineated\\ complex\\ core\\ of\\ mixed\\ signal\\ intensities\\ with\\ a\\ low\\ signal\\ hemosiderin\\ rim\\;\\ and\\,\\ with\\ enhancement\\ of\\ the\\ medial\\ aspect\\ of\\ the\\ core\\ after\\ contrast\\ administration\\.\ \(0\)\
\-\ cavernous\\ malformation\ \(20\)\
\-\ \\â\\€\\¢\\ cavernous\\ angioma\\ \\(cavernous\\ malformation\\)\ \(0\)\
\-\ \\â\\€\\¢\\ venous\\ angioma\ \(0\)\
\-\ \\â\\€\\¢\\ arteriovenous\\ malformation\ \(0\)\
\-\ \\â\\€\\¢\\ capillary\\ telangectasia\ \(0\)\
\-\ \\â\\€\\¢\\ hemorrhagic\\ neoplasm\ \(0\)\
\-\ 56\\ year\\-old\\ woman\\ with\\ worsening\\ headaches\\.\ \(1\)\
\-\ see\\ topic\ \(11\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cavernous\\:\\ 0\\.43249343994437317\ \(0\)\
\-\ malformation\\:\\ 0\\.3845458189932185\ \(0\)\
\-\ angioma\\:\\ 0\\.2616491462452442\ \(0\)\
\-\ core\\:\\ 0\\.2500372018332066\ \(0\)\
\-\ telangectasia\\:\\ 0\\.17931715962372013\ \(0\)\
\-\ delineated\\:\\ 0\\.1620883038542488\ \(0\)\
\-\ mr\\:\\ 0\\.161305923261115\ \(0\)\
\-\ intensities\\:\\ 0\\.15681858794716713\ \(0\)\
\-\ signal\\:\\ 0\\.1413188563384705\ \(0\)\
\-\ hemosiderin\\:\\ 0\\.13944829901404118\ \(0\)\
\-\ gradient\\:\\ 0\\.1308245731226221\ \(0\)\
\-\ capillary\\:\\ 0\\.1308245731226221\ \(0\)\
\-\ hereditary\\:\\ 0\\.12814554717839707\ \(0\)\
\-\ sequence\\:\\ 0\\.12575939550302426\ \(0\)\
\-\ look\\:\\ 0\\.12538585909939154\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.119567544985392\ \(0\)\
\-\ topic\\:\\ 0\\.11928558820240218\ \(0\)\
\-\ 56\\:\\ 0\\.11640279361468893\ \(0\)\
\-\ echo\\:\\ 0\\.11544214012767229\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.10812335998609329\ \(0\)\
\-\ mixed\\:\\ 0\\.1031802410154205\ \(0\)\
\-\ rim\\:\\ 0\\.09926340101009837\ \(0\)\
\-\ administration\\:\\ 0\\.09926340101009837\ \(0\)\
\-\ recommended\\:\\ 0\\.09915162916793636\ \(0\)\
\-\ of\\:\\ 0\\.09757227634109746\ \(0\)\
\-\ additional\\:\\ 0\\.0966275169308231\ \(0\)\
\-\ complex\\:\\ 0\\.0960395528267566\ \(0\)\
\-\ worsening\\:\\ 0\\.09518624645627605\ \(0\)\
\-\ headaches\\:\\ 0\\.09297716007571932\ \(0\)\
\-\ studies\\:\\ 0\\.09143598124130341\ \(0\)\
\-\ since\\:\\ 0\\.09029167019194145\ \(0\)\
\-\ required\\:\\ 0\\.08899318838165425\ \(0\)\
\-\ venous\\:\\ 0\\.08899318838165425\ \(0\)\
\-\ neoplasm\\:\\ 0\\.08509107893612607\ \(0\)\
\-\ cases\\:\\ 0\\.08383883622066296\ \(0\)\
\-\ medial\\:\\ 0\\.08113641824243047\ \(0\)\
\-\ aspect\\:\\ 0\\.08041518618864915\ \(0\)\
\-\ some\\:\\ 0\\.07842733025047302\ \(0\)\
\-\ see\\:\\ 0\\.07753876969423835\ \(0\)\
\-\ include\\:\\ 0\\.07416444704518096\ \(0\)\
\-\ with\\:\\ 0\\.0732229318147208\ \(0\)\
\-\ enhancement\\:\\ 0\\.07174524012735183\ \(0\)\
\-\ lesions\\:\\ 0\\.07158678151055484\ \(0\)\
\-\ low\\:\\ 0\\.07152371841483851\ \(0\)\
\-\ follow\\:\\ 0\\.06719611587584211\ \(0\)\
\-\ woman\\:\\ 0\\.06491710512361971\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06480105945789566\ \(0\)\
\-\ to\\:\\ 0\\.062323528712627765\ \(0\)\
\-\ up\\:\\ 0\\.06165868690001539\ \(0\)\
\-\ contrast\\:\\ 0\\.06056393609359488\ \(0\)\
\-\ after\\:\\ 0\\.060468806002121255\ \(0\)\
\-\ well\\:\\ 0\\.060355193887436064\ \(0\)\
\-\ treatment\\:\\ 0\\.059376473969047966\ \(0\)\
\-\ images\\:\\ 0\\.05765801566558919\ \(0\)\
\-\ normal\\:\\ 0\\.050892957630266786\ \(0\)\
\-\ the\\:\\ 0\\.0497435998480268\ \(0\)\
\-\ are\\:\\ 0\\.04729826101043647\ \(0\)\
\-\ no\\:\\ 0\\.0405341232346637\ \(0\)\
\-\ for\\:\\ 0\\.037779863323370785\ \(0\)\
\-\ and\\:\\ 0\\.02575699074649411\ \(0\)\
